• No results found

Hemophilia on the treshold of the 21st century Plug, I.

N/A
N/A
Protected

Academic year: 2021

Share "Hemophilia on the treshold of the 21st century Plug, I."

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Plug, I. (2005, September 6). Hemophilia on the treshold of the 21st century. Retrieved from https://hdl.handle.net/1887/3389

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/3389

(2)

Hemophilia on the threshold of the 21

st

century

(3)

Novo Nordisk Farma B.V., Sanquin, W yeth Pharmaceuticals and ZLB Behring generously provided support for the printing of this thesis.

Cover design: Painting by Arie M euldijk, 1991 Printed by: Optima Grafische Communicatie Lay out: Yvonne Souverein

(4)

Hemophilia on the threshold of the 21

st

century

PROEFSCHRIFT

t

er

verkri

j

gi

ng

van

de

graad

van

Doct

or

aan

de

Uni

versi

t

ei

t

Lei

den

op

gezag

van

Rect

or

M agni

fi

cus

Dr.

D.

D.

Brei

mer

hoogl

eraar

i

n

de

facul

t

ei

t

der

W i

skunde

en

Nat

uurwet

enschappen

en

di

e

der

Geneeskunde,

vol

gens

besl

ui

t

van

het

Col

l

ege

voor

Promot

i

es

t

e

verdedi

gen

op

di

nsdag

6

sept

ember

2005

t

er

kl

okke

14.

15

uur

door

Iri

s

Pl

ug

geboren

t

e

Geervl

i

et

(5)

Co-promotor: Dr J.G. van der Bom

Referent: Prof. dr E. Briët (Sanquin) Overige leden: Prof. dr J.P. Vandenbroucke

(6)

The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!', but 'That's funny...'

Isaak Asimov

(7)
(8)

7

Table of contents

Chapter 1

General introduction 11

Chapter 2

Outcome and side effects of treatment of hemophilia

2.1 M ortality and causes of death in patients with hemophilia,1992-2001 19 2.2 Thirty years of hemophilia treatmentin the Netherlands,1972-2001 39

2.3 Socialfunctioning of patients with hemophilia 65

2.4 Hepatitis C infection among Dutch hemophilia patients:a nationwide

cross-sectionalstudy into prevalence and antiviraltreatment 81

2.5 The uptake of recombinantfactor VIII in the Netherlands 99

Chapter 3

Female carriers of hemophilia

3.1 Bleeding in carriers of hemophilia 127

General Discussion 145

Summary 157

Samenvatting 163

Nawoord 169

(9)

Referenties

GERELATEERDE DOCUMENTEN

Since expression of Serpins may facilitate the immune escape of HLA positive tumors, we next analysed the effect of Serpin expression on survival in cases with normal/partial

Detection of amyloid plaques in mouse models of Alzheimer’s disease by magnetic resonance imaging.. Apostolova

• Although in the literature the level of 0.40 IU/ml is used to define mild hemophilia and is related to bleeding, we also found increased risk of bleeding in women with

We compared different age categories, and children were defined as patients younger than 16, adolescents as patients between 16 and 25 and adults as patients aged above 25

De levensverwachting van hemofiliepatiënten wordt nog steeds sterk beïnvloed door de gevolgen van hepatitis C en het humaan immunodeficiëntie virus (hiv).. Ook bij gebruik

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on

This shape also occurs in the combination artefacts (see below). The shape is the result of intensive use in a repetitive abrasive motion, carried out from different angles. In